Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ravic

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Acta Neurochirurgica. Supplement|October 9, 2003
Intracavitary treatment of malignant gliomas: radioimmunotherapy targeting fibronectinM Ravic
Journal of Clinical Psychopharmacology|October 1, 1986
A double-blind comparison of minaprine and imipramine in the treatment of depressed patientsN Bohacek, M Ravic, K Bizière
Postgraduate Medical Journal|January 1, 1990
Clinical pharmacological studies of some possible interactions of lornoxicam with other drugsM Ravic, A Johnston, P Turner
Drugs Under Experimental and Clinical Research|January 1, 1987
Minaprine and imipramine in the treatment of major depressive disorders. A comparative double-blind studyN Bohacek, M Ravic, K Bizière
Drugs|January 1, 1993
Renal and general tolerability of repeated doses of nimesulide in normal subjectsS J Warrington, M Ravic, A Dawnay
Human & Experimental Toxicology|November 1, 1990
A study of the interaction between lornoxicam and warfarin in healthy volunteersM Ravic, A Johnston, P Turner, et al.
Human & Experimental Toxicology|January 1, 1992
Does bismuth chelate influence lornoxicam absorption?M Ravic, A Johnston, P Turner, et al.
Alimentary Pharmacology & Therapeutics|June 26, 2003
Acid inhibition on the first day of dosing: comparison of four proton pump inhibitorsD Pantoflickova, G Dorta, M Ravic, et al.
Human & Experimental Toxicology|September 1, 1991
The effect of repeated oral doses of lornoxicam on antipyrine elimination in normal human volunteersM Ravic, A Johnston, P Turner, et al.
Alimentary Pharmacology & Therapeutics|April 16, 2003
Safety and efficacy of 7-day rabeprazole- and omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with documented peptic ulcer diseaseC J Hawkey, J C Atherton, H C Treichel, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Acta Neurochirurgica. Supplement|October 9, 2003
Intracavitary treatment of malignant gliomas: radioimmunotherapy targeting fibronectinM Ravic
Journal of Clinical Psychopharmacology|October 1, 1986
A double-blind comparison of minaprine and imipramine in the treatment of depressed patientsN Bohacek, M Ravic, K Bizière
Postgraduate Medical Journal|January 1, 1990
Clinical pharmacological studies of some possible interactions of lornoxicam with other drugsM Ravic, A Johnston, P Turner
Drugs Under Experimental and Clinical Research|January 1, 1987
Minaprine and imipramine in the treatment of major depressive disorders. A comparative double-blind studyN Bohacek, M Ravic, K Bizière
Drugs|January 1, 1993
Renal and general tolerability of repeated doses of nimesulide in normal subjectsS J Warrington, M Ravic, A Dawnay
Human & Experimental Toxicology|November 1, 1990
A study of the interaction between lornoxicam and warfarin in healthy volunteersM Ravic, A Johnston, P Turner, et al.
Human & Experimental Toxicology|January 1, 1992
Does bismuth chelate influence lornoxicam absorption?M Ravic, A Johnston, P Turner, et al.
Alimentary Pharmacology & Therapeutics|June 26, 2003
Acid inhibition on the first day of dosing: comparison of four proton pump inhibitorsD Pantoflickova, G Dorta, M Ravic, et al.
Human & Experimental Toxicology|September 1, 1991
The effect of repeated oral doses of lornoxicam on antipyrine elimination in normal human volunteersM Ravic, A Johnston, P Turner, et al.
Alimentary Pharmacology & Therapeutics|April 16, 2003
Safety and efficacy of 7-day rabeprazole- and omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with documented peptic ulcer diseaseC J Hawkey, J C Atherton, H C Treichel, et al.
Pageof 2